Angiotech Pharmaceuticals, Inc.

Pharmaceutical firm forms venture initiative

Published in Law and Health Weekly, July 2nd, 2005

Angiotech Pharmaceuticals, Inc., (ANPI, ANP) announced the formation of a new division focused on venture stage investing and new venture relationship development and management, Angiotech Drug Device Venture and Capital Enterprises (ADDVANCE).

ADDVANCE intends to commit capital of up to $50 million over the next 3 years to development stage companies and new enterprises.

ADDVANCE partners and employees, working together with Angiotech scientists and clinicians, will explore novel commercialization avenues for Angiotech technology and intellectual property outside of Angiotech's core therapeutic areas of interest.

The initial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2005-07-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry